Crossmark

A quadruple dissociation of reward-related behaviour in mice across excitatory inputs to the nucleus accumbens shell

Crossref DOI link: https://doi.org/10.1038/s42003-023-04429-6

Published Online: 2023-01-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lind, Erin B. https://orcid.org/0000-0003-2198-9922
Sweis, Brian M. https://orcid.org/0000-0002-2123-5824
Asp, Anders J.

Esguerra, Manuel

Silvis, Keelia A.

David Redish, A. https://orcid.org/0000-0003-3644-9072
Thomas, Mark J. https://orcid.org/0000-0001-5721-5350
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA019666)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA041808)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (K02 DA035459)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (P30 DA048742)

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

Breyer-Longden Family Foundation

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse

U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
License Information

Text and Data Mining valid from 2023-01-30

Version of Record valid from 2023-01-30
More Information

Article History

Received: 25 March 2021

Accepted: 5 January 2023

First Online: 30 January 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below